Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
20 studies found for:    TRICHOHEPATOENTERIC SYNDROME 1
Show Display Options
Rank Status Study
1 Completed The 1 Year Follow-up Objective Oral Appliance Compliance
Condition: Sleep-disordered Breathing
Intervention: Device: Mandibular Advancement Device
2 Enrolling by invitation Predicting Pathological Response Within the 1st Week of Chemotherapy Using Diffuse Optical Spectroscopic Imaging
Condition: Breast Cancer
Intervention: Device: Diffuse Optical Spectroscopy Imaging
3 Not yet recruiting Defining the Optimal Cryoballoon Duration Therapy for Treatment of Atrial Fibrillation: Defining the Optimal Cryoballoon Duration Therapy for Treatment of Atrial Fibrillation: The 1-2-3 Study
Condition: Atrial Fibrillation
Intervention: Other: Cryoballoon ablation
4 Terminated Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma
Condition: Glioblastoma
Interventions: Drug: Cetuximab;   Drug: Cilengitide EMD 121974
5 Not yet recruiting Ipilimumab and Dabrafenib in the 1st Line Tx of Unresectable Stage III/IV Melanoma
Condition: Stage III or IV Melanoma
Intervention: Drug: ipilimumab and dabrafenib
6 Unknown  Down Syndrome - Comparison of Screening Methods in the 1st and 2nd Trimesters
Conditions: Down Syndrome;   Chromosome Abnormalities
Interventions: Procedure: Ultrasound;   Procedure: Serum screen
7 Completed Clinical Analysis of the Influence of Using the Skin Care Products on the Diaper Area in Comparison With Using a Cotton Wool Cloth, Moistened With Clear Water on the Skin Physiology of the Newborns From the 1st Day to the 4th Week of Life
Condition: Postnatal Skin Physiology
8 Active, not recruiting A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type Patients
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Cetuximab + Oxaliplatin + 5FU/FA;   Drug: Oxaliplatin + 5FU/FA
9 Recruiting Azilsartan Circadian and Sleep Pressure
Condition: Hypertension
Interventions: Drug: Azilsartan;   Drug: Amlodipine
10 Completed A Trial of Meal Replacement at a Community Diabetes Clinic Serving a Low Socioeconomic Hispanic Population
Conditions: Type 2 Diabetes;   Obesity
Interventions: Other: Meal Replacement;   Other: Standard Care
11 Recruiting Salt Iodization: Meeting the Needs of Pregnancy, Lactation and Infancy
Condition: Iodine Deficiency
12 Completed Effect of Adductor-Canal-Blockade on High Pain Responders After Total Knee Arthroplasty
Condition: Pain After Total Knee Arthroplasty
Interventions: Drug: Ropivacaine;   Drug: Saline
13 Withdrawn Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Hormone Treatment (PRED-IGF)
Condition: Idiopathic Short Stature
Intervention: Drug: Nutropin [Somatropin (rDNA origin) for injection]
14 Unknown  Helicobacter Pylori Immune Thrombocytopenic Purpura
Condition: Immune Thrombocytopenic Purpura
15 Completed A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients
Condition: HIV Infections
Interventions: Drug: Nucleoside Reverse Transcriptase Inhibitor (NRTIs);   Drug: ritonavir;   Drug: saquinavir [Invirase]
16 Terminated
Has Results
High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer
Conditions: Stage IV Colon Cancer;   Stage IV Rectal Cancer
Interventions: Drug: leucovorin calcium;   Biological: bevacizumab;   Dietary Supplement: cholecalciferol;   Drug: fluorouracil;   Drug: oxaliplatin;   Other: pharmacological study
17 Withdrawn Vitamin D and Carboxy PTH Fragments in Coronary Calcification
Conditions: Coronary Calcification;   Endstage Renal Disease;   Parathyroid Hormone
Interventions: Drug: Doxercalciferol administration;   Drug: Doxercalciferol administered by 1-84-7-84
18 Active, not recruiting Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer
Conditions: Breast Cancer;   Triple Negative Breast Cancer;   Metastatic Breast Cancer
Interventions: Drug: AZD2281;   Drug: Paclitaxel
19 Unknown  Ghana Newborn Home Visits Neonatal Mortality Trial
Condition: Neonatal Mortality
Intervention: Behavioral: Home visits
20 Completed Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge
Condition: Hepatitis B
Intervention: Biological: Engerix™-B Kinder

Indicates status has not been verified in more than two years